文献速递眼底病与葡萄膜炎

非感染性葡萄膜炎与精神疾病共病风险增加:All of Us研究项目分析

Noninfectious Uveitis is Associated With Increased Psychiatric Comorbidities: An All of Us Research Program Analysis.
PubMed 文献 · Am J Ophthalmol · 2026-07-21

这项回顾性横断面研究基于All of Us数据库,比较了3266例非感染性葡萄膜炎(NIU)患者与9798例匹配对照者的精神疾病共病频率及PHQ筛查工具使用情况。结果显示NIU患者多种精神疾病共病频率显著升高,尤其在黑人参与者中抑郁、焦虑及物质滥用的关联更强,而PHQ-2和PHQ-9使用率分别仅为4.8%和1.4%。

要点

  • NIU患者人格障碍、情绪障碍、抑郁、焦虑、失眠等精神共病频率均显著高于匹配对照。
  • NIU与抑郁、焦虑、物质滥用及阿片类滥用的关联在黑人参与者中比白人更强。
  • NIU患者中PHQ-2和PHQ-9问卷使用率很低,分别为4.8%和1.4%。

核心结论

  • NIU与精神疾病共病存在强关联,尤其在黑人患者中更为显著。
  • 建议对NIU患者进行精神共病筛查工具的早期观察与使用。

研究设计与样本

  • 回顾性横断面研究,使用All of Us数据库,通过ICD10CM-H44.13和SNOMED 128473001检索NIU病例并按1:3匹配对照。
  • NIU患者3266例,匹配对照9798例,匹配变量包括种族、年龄、性别、族裔、吸烟状态及健康社会决定因素。
  • 采用Wald检验逻辑回归比较两组,P < .05为差异有统计学意义。

主要发现

  • NIU患者人格障碍频率5.2%(OR 3.74 [2.97-4.75]),情绪障碍46.4%(OR 3.31 [3.08-3.56])。
  • 抑郁障碍44.0%(OR 3.34 [3.10-3.60]),焦虑44.3%(OR 3.13 [2.92-3.37]),失眠25.3%(OR 2.93 [2.60-3.30])。
  • 物质滥用16.1%(OR 2.34 [2.05-2.67]),精神分裂症3.0%(OR 2.38 [1.70-3.31]),双相障碍7.8%(OR 2.16 [1.81-2.60]),阿片类滥用3.0%(OR 2.06 [1.59-2.69]),所有P < .05。
  • NIU与抑郁、焦虑、物质滥用及阿片类滥用的关联在黑人参与者中比白人参与者更强。
  • NIU患者中PHQ-2和PHQ-9问卷使用率分别为4.8%和1.4%。

关键数值与推荐

  • NIU病例定义采用ICD10CM-H44.13和SNOMED 128473001。
  • 精神疾病分析限于与精神健康相关且在All of Us数据库中具有足够统计效力的病种。
  • 统计显著性阈值P < .05。

临床怎么用

  • 眼科检查时应对NIU患者常规考虑精神共病筛查,尤其关注黑人患者。
  • 使用PHQ-2和PHQ-9等筛查工具有助于早期发现抑郁等精神症状。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to evaluate the psychiatric comorbidities of noninfectious uveitis (NIU) and screening tool usage through a matched case-control approach. DESIGN: Retrospective cross-sectional study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: Patients with NIU and without NIU were chosen from the All of Us database with consent and information provided via electronic health records. METHODS: The All of Us database was searched for NIU cases using International Classification of Diseases (ICD) and Systematized Nomenclature of Medicine: ICD10CM-H44.13 and Systematized Nomenclature of Medicine 128473001, and matched controls (1:3). Comorbidity frequencies for NIU patients (n = 3266) and case controls (n = 9798), and PHQ screening tool usage were recorded. Case controls were matched across all demographic variables offered through All of Us: race, age, sex, ethnicity, smoking status, and social determinants of health, including employment status, income, education, and insurance status. Wald's test logistic regression compared both groups (P < .05). MAIN OUTCOME MEASURES: Frequency of psychiatric comorbidities in NIU patients and control patients, including across race. Frequency of mental health screening usage among NIU patients. Psychiatric diseases were selected for analysis based on their pertinence to psychiatric health and were among the few that were sufficiently powered from the possible comorbidities in the All of Us database. RESULTS: NIU patients had higher frequency of personality disorder (5.2%, OR 3.74 [2.97-4.75]), mood disorder (46.4%, OR 3.31 [3.08-3.56]), depressive disorder (44.0%, OR 3.34 [3.10-3.60]), anxiety (44.3%, OR 3.13 [2.92-3.37]), insomnia (25.3%, OR 2.93 [2.60-3.30]), substance abuse (16.1%, OR 2.34 [2.05-2.67]), schizophrenia (3.0%, OR 2.38 [1.70-3.31]), bipolar disorder (7.8%, OR 2.16 [1.81-2.60]), and opioid abuse (3.0%, OR 2.06 [1.59-2.69]) (P < .05, all). The association between NIU and depression, anxiety, substance and opioid abuse was stronger in Black participants than White participants. The frequency of PHQ-2 and PHQ-9 questionnaire usage was low among NIU patients, with a total of 4.8% and 1.4%, respectively. CONCLUSIONS: NIU is strongly associated with psychiatric comorbidities, particularly in Black patients. Ophthalmologic examination and the use of screening tools for psychiatric comorbidities can provide early observation of symptoms and are recommended in NIU patients.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Marella P, Subramanian V, Habiel M, et al. Noninfectious Uveitis is Associated With Increased Psychiatric Comorbidities: An All of Us Research Program Analysis. Am J Ophthalmol. 2026. PMID: 42480826. doi:10.1016/j.ajo.2026.07.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。